OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME
    1.
    发明申请
    OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME 审中-公开
    来自长链多脂脂肪酸的氧化锌及其制备和使用方法

    公开(公告)号:US20110190389A1

    公开(公告)日:2011-08-04

    申请号:US12531344

    申请日:2008-02-20

    摘要: Disclosed are novel oxylipins, referred to herein as docosanoids and eicosanoids, that are derived from C22 polyunsaturated fatty acids and from C20 polyunsaturated fatty acids, respectively, and methods of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6), docosatrienoic acid (C22:3n-3) (DTrAn-3), docosadienoic acid (C22:2n-6) (DDAn-6), eicosatrienoic acid (C20:3n-3) (ETrAn-3) eicosapentaenoic acid and arachidonic acid as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUF A)-rich oils and compositions that contain enhanced and effective amounts of LCPUF A-derived oxylipins, and particularly, docosanoids.

    摘要翻译: 公开了分别衍生自C22多不饱和脂肪酸和C20多不饱和脂肪酸的新型牛脂素,本文称为二十二烷酸类和类二十烷酸,以及制备和使用这些牛脂素的方法。 还公开了二十二碳五烯酸(C22:5n-6)(DPAn-6),二十二碳五烯酸(C22:5n-3)(DPAn-3)和二十二碳四烯酸(DTAn-6:C22:4n-6) ,二十二碳三烯酸(C22:3n-3)(DTrAn-3),二十二碳烯酸(C22:2n-6)(DDAn-6),二十碳三烯酸(C20:3n-3)(ETrAn-3)二十碳五烯酸和花生四烯酸 作为生产新型oxylipins的底物,以及由此产生的oxylipin。 还公开了在治疗和营养或美容应用中使用DPAn-6,DPAn-3,DTAn-6和/或由其衍生的oxylipin,和/或衍生自C22脂肪酸结构的新型二醇类,特别是作为 抗炎或抗神经变性化合物。 本发明还涉及生产长链多不饱和酸(LCPUF A)的油和组合物的新方法,其含有增强和有效量的LCPUF A衍生的草甘膦脂类,特别是二十二烷酸。

    Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
    2.
    发明授权
    Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same 失效
    来自长链多不饱和脂肪酸的牛痘素及其制备和使用方法

    公开(公告)号:US07884131B2

    公开(公告)日:2011-02-08

    申请号:US11284790

    申请日:2005-11-21

    IPC分类号: A61K31/22 C07C59/00 C07C57/00

    摘要: Disclosed are novel oxylipins, referred to herein as docosanoids, that are derived from C22 polyunsaturated fatty acids, and method of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6) as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids, in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of LCPUFA-derived oxylipins, and particularly, docosanoids.

    摘要翻译: 公开了衍生自C22多不饱和脂肪酸的新型oxylipin,本文称为多糖类,以及制备和使用这种oxylipin的方法。 还公开了二十二碳五烯酸(C22:5n-6)(DPAn-6),二十二碳五烯酸(C22:5n-3)(DPAn-3)和二十二碳四烯酸(DTAn-6:C22:4n-6) 作为生产新型oxylipins的底物,以及由此产生的oxylipin。 还公开了在治疗和营养或化妆品应用中使用DPAn-6,DPAn-3,DTAn-6和/或衍生自其的oxylipin,和/或衍生自C22脂肪酸结构的新型二十二烷酸,特别是 作为抗炎或抗神经变性化合物。 本发明还涉及生产长链多不饱和酸(LCPUFA)的油和组合物的新方法,其含有增强和有效量的LCPUFA衍生的草甘膦脂类,尤其是二十二烷酸。

    Oxylipins From Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
    3.
    发明申请
    Oxylipins From Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same 审中-公开
    来自长链多不饱和脂肪酸的Oxylipins及其制备和使用方法

    公开(公告)号:US20110178047A1

    公开(公告)日:2011-07-21

    申请号:US12981261

    申请日:2010-12-29

    摘要: Disclosed are novel oxylipins, referred to herein as docosanoids, that are derived from C22 polyunsaturated fatty acids, and method of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6) as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids, in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of LCPUFA-derived oxylipins, and particularly, docosanoids.

    摘要翻译: 公开了衍生自C22多不饱和脂肪酸的新型oxylipin,本文称为多糖类,以及制备和使用这种oxylipin的方法。 还公开了二十二碳五烯酸(C22:5n-6)(DPAn-6),二十二碳五烯酸(C22:5n-3)(DPAn-3)和二十二碳四烯酸(DTAn-6:C22:4n-6) 作为生产新型oxylipins的底物,以及由此产生的oxylipin。 还公开了在治疗和营养或化妆品应用中使用DPAn-6,DPAn-3,DTAn-6和/或衍生自其的oxylipin,和/或衍生自C22脂肪酸结构的新型二十二烷酸,特别是 作为抗炎或抗神经变性化合物。 本发明还涉及生产长链多不饱和酸(LCPUFA)的油和组合物的新方法,其含有增强和有效量的LCPUFA衍生的草甘膦脂类,尤其是二十二烷酸。

    Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
    8.
    发明申请
    Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same 失效
    来自长链多不饱和脂肪酸的牛痘素及其制备和使用方法

    公开(公告)号:US20060241088A1

    公开(公告)日:2006-10-26

    申请号:US11284790

    申请日:2005-11-21

    IPC分类号: A61K31/60 A61K31/22 C07C69/02

    摘要: Disclosed are novel oxylipins, referred to herein as docosanoids, that are derived from C22 polyunsaturated fatty acids, and method of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6) as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids, in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of LCPUFA-derived oxylipins, and particularly, docosanoids.

    摘要翻译: 公开了衍生自C22多不饱和脂肪酸的新型oxylipin,本文称为多糖类,以及制备和使用这种oxylipin的方法。 还公开了二十二碳五烯酸(C22:5n-6)(DPAn-6),二十二碳五烯酸(C22:5n-3)(DPAn-3)和二十二碳四烯酸(DTAn-6:C22:4n-6) 作为生产新型oxylipins的底物,以及由此产生的oxylipin。 还公开了在治疗和营养或化妆品应用中使用DPAn-6,DPAn-3,DTAn-6和/或衍生自其的oxylipin,和/或衍生自C22脂肪酸结构的新型二十二烷酸,特别是 作为抗炎或抗神经变性化合物。 本发明还涉及生产长链多不饱和酸(LCPUFA)的油和组合物的新方法,其含有增强和有效量的LCPUFA衍生的草甘膦脂类,尤其是二十二烷酸。

    Service restriction apparatus and method for portable communication device
    10.
    发明申请
    Service restriction apparatus and method for portable communication device 审中-公开
    用于便携式通信设备的服务限制装置和方法

    公开(公告)号:US20070238449A1

    公开(公告)日:2007-10-11

    申请号:US11729432

    申请日:2007-03-28

    IPC分类号: H04M3/42

    摘要: A service restriction apparatus and method for a portable phone. A utilization restriction method for a portable communication device includes determining whether a service restriction function is activated when an incoming or outgoing call request is detected; determining whether a phone number of the incoming or outgoing call is registered in a communication-allowed phone number list if a service restriction function is activated; attempting to process the incoming or outgoing call if the phone number is registered in the communication-allowed phone number list; and blocking the incoming or outgoing call if the phone number is not registered in the communication-allowed phone number list.

    摘要翻译: 一种用于便携式电话的服务限制装置和方法。 一种用于便携式通信设备的利用限制方法包括:当检测到呼入或呼出呼叫请求时确定服务限制功能是否被激活; 如果启用了服务限制功能,则确定在通话允许的电话号码列表中是否登记了呼入或呼出电话的电话号码; 如果电话号码注册在通信允许的电话号码列表中,则尝试处理来电或去电; 如果电话号码没有注册在允许通信的电话号码列表中,则阻止呼入或拨出呼叫。